Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101786-101786
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis
Vanessa Piechotta, Waldemar Siemens, Iris Thielemann, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 6, pp. 379-391
Open Access | Times Cited: 51
New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis of cohort studies
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 27
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants
Cristina V. Cardemil, Yi Cao, Christine M. Posavad, et al.
PEDIATRICS (2024) Vol. 153, Iss. 3
Open Access | Times Cited: 10
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
Ching‐Wen Hou, Stacy Williams, Veronica Boyle, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 61-61
Open Access
Pediatric COVID-19 severity by SARS-CoV-2 lineage and vaccine status in Canada: an IMPACT study
Daniel S. Farrar, Julie A. Bettinger, Aaron Campigotto, et al.
Pediatric Research (2025)
Closed Access
Genomic Epidemiology of the Main SARS‐CoV‐2 Variants Circulating in Italy During the Omicron Era
Annalisa Bergna, Alessia Lai, Fabio Sagradi, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Open Access
Seroprevalence of SARS-CoV-2 infection among hospitalized children at a tertiary care center in North-East India
Chabungbam Smilie, Sareet Kumari Nandeibam, Chongtham Shyamsunder Singh, et al.
Journal of Tropical Pediatrics (2025) Vol. 71, Iss. 2
Closed Access
Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Exosomes, and the potential for exosome‐based interventions against COVID‐19
Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial
Amparo L. Figueroa, Dania Torres, Celia Reyes-Acuna, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 3
Impact of COVID-19 Pandemic on the Clinical Course and Complications of Varicella—A Retrospective Cohort Study
Maja Pietrzak, Maria Pokorska‐Śpiewak
Pediatric Reports (2024) Vol. 16, Iss. 2, pp. 451-460
Open Access | Times Cited: 2
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults
Gro Tunheim, Even Fossum, Anna Hayman Robertson, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Severe Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children From Wild-type to Population Immunity: A Prospective Multicenter Cohort Study With Real-time Reporting
Adam J. Tulling, Gertjan Lugthart, Miriam G. Mooij, et al.
The Pediatric Infectious Disease Journal (2023) Vol. 42, Iss. 12, pp. 1077-1085
Open Access | Times Cited: 7
Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years
Liang En Wee, Nicole K. Y. Tang, Deanette Pang, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 12, pp. 1324-1324
Closed Access | Times Cited: 7
Effectiveness of COVID-19 vaccines among children 6–11 years against hospitalization during Omicron predominance in Malaysia
Vivek Jason Jayaraj, Masliyana Husin, Jing Lian Suah, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Retrospective Analysis of Clinical Characteristics and Disease Outcomes in Children and Adolescents Hospitalized Due to COVID-19 Infection in Tunisia
Aida Borgi, Khaoula Meftah, Inès Trabelsi, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 779-779
Open Access | Times Cited: 1
SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response
Eric R. A. Vos, Cheyenne C. E. van Hagen, Denise Wong, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 1
Generalizability of anti-SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between two weighting methods
Adrien Saucier, Bouchra Nasri, Britt McKinnon, et al.
American Journal of Epidemiology (2024)
Open Access | Times Cited: 1
Spatial Prediction of Human Brucellosis Susceptibility Using an Explainable Optimized Adaptive Neuro Fuzzy Inference System
Ali Jafari, Ali Asghar Alesheikh, Iman Zandi, et al.
Acta Tropica (2024), pp. 107483-107483
Closed Access | Times Cited: 1
Post-coronavirus disease 2019–associated symptoms among children and adolescents in the SARS-CoV-2 Omicron era
Anne Schlegtendal, Christoph Maier, Julien Stein, et al.
European Journal of Pediatrics (2024) Vol. 184, Iss. 1
Open Access | Times Cited: 1
Considerations for vaccinating children against COVID-19
John Hart, Darren Suryawijaya Ong, Kulkanya Chokephaibulkit, et al.
BMJ Paediatrics Open (2023) Vol. 7, Iss. 1, pp. e001964-e001964
Open Access | Times Cited: 4
Incidence of idiopathic nephrotic syndrome during the Covid-19 pandemic in the Paris area (France) and in the Netherlands
Floor Veltkamp, Victoire Thenot, Carlijn Mussies, et al.
Pediatric Nephrology (2023) Vol. 38, Iss. 11, pp. 3681-3692
Open Access | Times Cited: 3
Interim Safety and Immunogenicity of COVID-19 Omicron-BA.1 Variant-Containing Vaccine in Children
Avika Dixit, Richard L. Bennett, Kashif Ali, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top